Nuvalent (NUVL) Return on Equity [ROE] (2021 - 2026)
Nuvalent (NUVL) recorded Return on Equity [ROE] of -37.16% in Q1 2026, down 8.24 percentage points from -28.92% a year earlier but up 3.48 percentage points from the prior quarter.
Powered by 
Analysis
Nuvalent (NUVL) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Nuvalent reported Return on Equity [ROE] of -36.70%, down 7.24 percentage points from FY2024.
- Annual Return on Equity [ROE] has a four-year change of -0.67 percentage points (FY2021 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -29.46% in FY2024 (-7.77 pp), -21.70% in FY2023 (+0.19 pp), -21.89% in FY2022 (+14.14 pp) and -36.03% in FY2021.
- Quarterly Return on Equity [ROE] has ranged from -42.74% in Q3 2025 to -15.63% in Q4 2021 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -7.56 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 2.39 percentage points in Q3 2024, against a drop of 17.22 percentage points in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -40.63% (Q4 2025), -42.74% (Q3 2025) and -35.20% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | -37.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -37.16% |
| Dec 31, 2025 | -40.63% |
| Sep 30, 2025 | -42.74% |
| Jun 30, 2025 | -35.20% |
| Mar 31, 2025 | -28.92% |
| Dec 31, 2024 | -23.81% |
| Sep 30, 2024 | -25.51% |
| Jun 30, 2024 | -26.46% |
| Mar 31, 2024 | -21.16% |
| Dec 31, 2023 | -23.02% |
| Sep 30, 2023 | -27.90% |
| Jun 30, 2023 | -23.14% |
| Mar 31, 2023 | -19.73% |
| Dec 31, 2022 | -23.39% |
| Sep 30, 2022 | -29.87% |
| Jun 30, 2022 | -25.22% |
| Mar 31, 2022 | -20.65% |
| Dec 31, 2021 | -15.63% |
| Sep 30, 2021 | -26.56% |
API Access
Nuvalent Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NUVL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NUVL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NUVL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();